11 studies found for:    eosinophil AND NIAID | Open Studies | Exclude Unknown
Show Display Options
Rank Status Study
1 Recruiting Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Conditions: Asthma;   Eosinophilia;   Helminthiasis;   Hypersensitivity;   Parasitic Disease
Intervention:
2 Recruiting Imatinib Mesylate to Treat Myeloproliferative Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Intervention: Drug: Imatinib Mesylate
3 Recruiting A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
Condition: Familial Hypereosinophilia
Intervention:
4 Recruiting Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Intervention: Drug: Dexpramipexole
5 Recruiting A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa Infection
Condition: Loiasis
Interventions: Drug: Reslizumab;   Drug: Diethylcarbamazine;   Other: Placebo
6 Recruiting Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Interventions: Drug: benralizumab;   Other: Placebo
7 Recruiting Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
Conditions: Leukopheresis;   Plasmapheresis
Intervention:
8 Recruiting Steroid Treatment for Hypereosinophilic Syndrome
Condition: Hypereosinophilia
Intervention: Drug: Corticosteroids
9 Recruiting Collection of Peripheral Blood and Bone Marrow From Healthy Donors for Use in In Vitro Research
Condition: Eosinophilia
Intervention:
10 Recruiting Eosinophilic Esophagitis Databank
Conditions: Esophagitis;   Eosinophilic Esophagitis
Intervention:
11 Recruiting A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis
Condition: Churg-Strauss Syndrome
Interventions: Biological: Mepolizumab;   Drug: Placebo

Indicates status has not been verified in more than two years